Mutation of aspartic acid 262 on estrogen receptor abrogates estradiol signaling pathway

References

• Heldring N, Pike A, Andersson S, et al. Estrogen receptors: how do they signal and what are their targets. Physiol Rev. 2007;87(3):1–8. doi: 10.1152/physrev.00026.2006.
   PubMed Web of Science ®Google Scholar
• Fuentes N, Silveyra P. Estrogen receptor signaling mechanisms. Adv Protein Chem Struct Biol. 2019;116:135–170. doi: 10.1016/bs.apcsb.2019.01.001.
   PubMed Web of Science ®Google Scholar
• Billon-Gales A, Fontaine C, Filipe C, et al. The transactivating function 1 of estrogen receptor alpha is dispensable for the vasculoprotective actions of 17beta-estradiol. Proc Natl Acad Sci U S A. 2009;106(6):2053–2058. doi: 10.1073/pnas.0808742106.
   PubMed Web of Science ®Google Scholar
• Billon-Gales A, Krust A, Fontaine C, et al. Activation function 2 (AF2) of estrogen receptor-alpha is required for the atheroprotective action of estradiol but not to accelerate endothelial healing. Proc Natl Acad Sci U S A. 2011;108(32):13311–13316. doi: 10.1073/pnas.1105632108.
   PubMed Web of Science ®Google Scholar
• Abot A, Fontaine C, Raymond-Letron I, et al. The AF-1 activation function of estrogen receptor alpha is necessary and sufficient for uterine epithelial cell proliferation in vivo. Endocrinology. 2013;154(6):2222–2233. doi: 10.1210/en.2012-2059.
   PubMed Web of Science ®Google Scholar
• Adlanmerini M, Solinhac R, Abot A, et al. Mutation of the palmitoylation site of estrogen receptor alpha in vivo reveals tissue-specific roles for membrane versus nuclear actions. Proc Natl Acad Sci U S A. 2014;111(2):E283–90. doi: 10.1073/pnas.1322057111.
   PubMed Web of Science ®Google Scholar
• Pietras RJ, Szego CM. Specific binding sites for oestrogen at the outer surfaces of isolated endometrial cells. Nature. 1977;265(5589):69–72. doi: 10.1038/265069a0.
   PubMed Web of Science ®Google Scholar
• Szego CM, Davis JS. Adenosine 3′,5′-monophosphate in rat uterus: acute elevation by estrogen. Proc Natl Acad Sci U S A. 1967;58(4):1711–1718. doi: 10.1073/pnas.58.4.1711.
   PubMed Web of Science ®Google Scholar
• Hammes SR, Levin ER. Minireview: recent advances in extranuclear steroid receptor actions. Endocrinology. 2011;152(12):4489–4495. doi: 10.1210/en.2011-1470.
   PubMed Web of Science ®Google Scholar
• Simoncini T. Mechanisms of action of estrogen receptors in vascular cells: relevance for menopause and aging. Climacteric. 2009;12(Suppl 1):6–11. doi: 10.1080/13697130902986385.
   PubMedGoogle Scholar
• Kim KH, Bender JR. Membrane-initiated actions of estrogen on the endothelium. Mol Cell Endocrinol. 2009;308(1–2):3–8. doi: 10.1016/j.mce.2009.03.025.
   PubMed Web of Science ®Google Scholar
• Wu Q, Chambliss K, Umetani M, et al. Non-nuclear estrogen receptor signaling in the endothelium. J Biol Chem. 2011;286(17):14737–14743. doi: 10.1074/jbc.R110.191791.
   PubMed Web of Science ®Google Scholar
• Ueda K, Karas RH. Emerging evidence of the importance of rapid, non-nuclear estrogen receptor signaling in the cardiovascular system. Steroids. 2013;78(6):589–596. doi: 10.1016/j.steroids.2012.12.006.
   PubMed Web of Science ®Google Scholar
• Acconcia F, Ascenzi P, Bocedi A, et al. Palmitoylation-dependent estrogen receptor alpha membrane localization: regulation by 17beta-estradiol. Mol Biol Cell. 2005;16(1):231–237. doi: 10.1091/mbc.e04-07-0547.
   PubMed Web of Science ®Google Scholar
• Acconcia F, Ascenzi P, Fabozzi G, et al. S-palmitoylation modulates human estrogen receptor-alpha functions. Biochem Biophys Res Commun. 2004;316(3):878–883. doi: 10.1016/j.bbrc.2004.02.129.
   PubMed Web of Science ®Google Scholar
• Pedram A, Razandi M, Sainson RC, et al. A conserved mechanism for steroid receptor translocation to the plasma membrane. J Biol Chem. 2007;282(31):22278–22288. doi: 10.1074/jbc.M611877200.
   PubMed Web of Science ®Google Scholar
• Krust A, Green S, Argos P, et al. The chicken oestrogen receptor sequence: homology with v-erbA and the human oestrogen and glucocorticoid receptors. Embo J. 1986;5(5):891–897. doi: 10.1002/j.1460-2075.1986.tb04300.x.
   PubMed Web of Science ®Google Scholar
• Wu Q, Chambliss K, Lee WR, et al. Point mutations in the ERalpha galphai binding domain segregate nonnuclear from nuclear receptor function. Mol Endocrinol. 2013;27(1):2–11. doi: 10.1210/me.2011-1378.
   PubMedGoogle Scholar
• Hinshelwood MM, Corbin CJ, Tsang PC, et al. Isolation and characterization of a complementary deoxyribonucleic acid insert encoding bovine aromatase cytochrome P450. Endocrinology. 1993;133(5):1971–1977. doi: 10.1210/endo.133.5.8404644.
   PubMed Web of Science ®Google Scholar
• Adlanmerini M, Febrissy C, Zahreddine R, et al. Mutation of arginine 264 on ERalpha (estrogen receptor alpha) selectively abrogates the rapid signaling of estradiol in the endothelium without altering fertility. Arterioscler Thromb Vasc Biol. 2020;40(9):2143–2158. doi: 10.1161/ATVBAHA.120.314159.
   PubMed Web of Science ®Google Scholar
• Xu X, Yan Q, Liu X, et al. 17beta-Estradiol nongenomically induces vascular endothelial H(2)S release by promoting phosphorylation of cystathionine gamma-lyase. J Biol Chem. 2019;294(43):15577–15592. doi: 10.1074/jbc.RA119.008597.
   PubMed Web of Science ®Google Scholar
• O’Brien JE, Peterson TJ, Tong MH, et al. Estrogen-induced proliferation of uterine epithelial cells is independent of estrogen receptor alpha binding to classical estrogen response elements. J Biol Chem. 2006;281(36):26683–26692. doi: 10.1074/jbc.M601522200.
   PubMed Web of Science ®Google Scholar
• Chambliss KL, Wu Q, Oltmann S, et al. Non-nuclear estrogen receptor alpha signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice. J Clin Invest. 2010;120(7):2319–2330. doi: 10.1172/JCI38291.
   PubMed Web of Science ®Google Scholar
• Madak-Erdogan Z, Kim SH, Gong P, et al. Design of pathway preferential estrogens that provide beneficial metabolic and vascular effects without stimulating reproductive tissues. Sci Signal. 2016;9(429):ra53. doi: 10.1126/scisignal.aad8170.
   PubMed Web of Science ®Google Scholar
• Guo X, Razandi M, Pedram A, et al. Estrogen induces vascular wall dilation: mediation through kinase signaling to nitric oxide and estrogen receptors alpha and beta. J Biol Chem. 2005;280(20):19704–19710. doi: 10.1074/jbc.M501244200.
   PubMed Web of Science ®Google Scholar
• Mani S, Li H, Untereiner A, et al. Decreased endogenous production of hydrogen sulfide accelerates atherosclerosis. Circulation. 2013;127(25):2523–2534. doi: 10.1161/CIRCULATIONAHA.113.002208.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhao X, Jin H, et al. Role of hydrogen sulfide in the development of atherosclerotic lesions in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol. 2009;29(2):173–179. doi: 10.1161/ATVBAHA.108.179333.
   PubMed Web of Science ®Google Scholar
• Li X, Chen W, Li P, et al. Follicular stimulating hormone accelerates atherogenesis by increasing endothelial VCAM-1 expression. Theranostics. 2017;7(19):4671–4688. doi: 10.7150/thno.21216.
   PubMed Web of Science ®Google Scholar
• McLean AC, Valenzuela N, Fai S, et al. Performing vaginal lavage, crystal violet staining, and vaginal cytological evaluation for mouse estrous cycle staging identification. J Vis Exp. 2012;15(67):e4389. doi: 10.3791/4389.
   Google Scholar
• Bernelot Moens SJ, Schnitzler GR, Nickerson M, et al. Rapid estrogen receptor signaling is essential for the protective effects of estrogen against vascular injury. Circulation. 2012;126(16):1993–2004. doi: 10.1161/circulationaha.112.124529.
   PubMed Web of Science ®Google Scholar
• Arao Y, Hamilton KJ, Ray MK, et al. Estrogen receptor alpha AF-2 mutation results in antagonist reversal and reveals tissue selective function of estrogen receptor modulators. Proc Natl Acad Sci U S A. 2011;108(36):14986–14991. doi: 10.1073/pnas.1109180108.
   PubMed Web of Science ®Google Scholar